Nonsmall Cell Lung Cancer Clinical Trials

63 clinical trials for Nonsmall Cell Lung Cancer across international registries, including 8 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy — RECRUITING · PHASE2
• Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors — RECRUITING · PHASE1
• Evaluating the Efficacy and Safety of AI Localization Models in Multidisciplinary Team Care for NSCLC — RECRUITING · NA
• Assessing an Oral EGFR Inhibitor, DZD6008 in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN2) — RECRUITING · PHASE1
• Patient-centered, Optimal Integration of Survivorship and Palliative Care — RECRUITING · NA
• TCR-T Cell Immunotherapy of Lung Cancer and Other Solid Tumors — RECRUITING · PHASE1
• A Study of HS-10365 in Patients With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer — RECRUITING · PHASE2
• Dose-intensified neoadjuvant radiochemotherapy for operable locally advanced NSCLC Stage III A & B — RECRUITING
• A Phase 2 Study Adding Ascorbate to Chemotherapy and Radiation Therapy for NSCLC — ACTIVE_NOT_RECRUITING · PHASE2
• Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) — COMPLETED · PHASE3
• A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors — NOT_YET_RECRUITING · PHASE1
• Platform Study of JDQ443 in Combinations in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation — ACTIVE_NOT_RECRUITING · PHASE1
• NT-I7 in Combination With Atezolizumab in Previously Untreated, PD-L1-expressing, Locally Advanced or Metastatic NSCLC — TERMINATED · PHASE2
• Genomically Guided Radiation Dose Personalization in Locally Advanced NSCLC — COMPLETED · PHASE1
• Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR) — COMPLETED · PHASE3
• Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population — ACTIVE_NOT_RECRUITING
• A Study of HMBD-002, a Monoclonal Antibody Targeting VISTA, as Monotherapy and Combined With Pembrolizumab, in Patients With Advanced Solid Tumors — COMPLETED · PHASE1
• X-396(Ensartinib) Capsules in ALK-Positive NSCLC Patients With Brain Metastases — ACTIVE_NOT_RECRUITING · PHASE2
• Nintedanib in Molecularly Selected Patients With Advanced Non-Small Cell Lung Cancer — COMPLETED · PHASE2
• XP-102 and XP-102 in Combination With Trametinib in Advanced Solid Tumor Patients With a BRAF V600 Mutation — NOT_YET_RECRUITING · PHASE1
• Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With CRC, NSCLC, and STS — ACTIVE_NOT_RECRUITING · PHASE1
• Dasatinib and Osimertinib (AZD9291) in Advanced Non-Small Cell Lung Cancer With EGFR Mutations — TERMINATED · PHASE1
• First-in-Human Study of XMT-1592 in Patients With Ovarian Cancer and NSCLC Likely to Express NaPi2b — TERMINATED · PHASE1
• Role of Neutrophils and Electro-bioluminescence in the Rehabilitation — COMPLETED · PHASE1
• Skeletal Muscle Atrophy and Dysfunction in Human Cancer — COMPLETED · NA
• Atezolizumab as Induction Therapy in Non-small Cell Lung Cancer — COMPLETED · PHASE2
• Study of Durvalumab + Tremelimumab in NSCLC Patients After Adjuvant Treatment — WITHDRAWN · PHASE2
• A Study of [14C]GB491 in Male Healthy Subjects — COMPLETED · PHASE1
• A Study to Evaluate Safety, PK and Efficacy of HS-10296 in Patients With NSCLC — OTHER · PHASE1
• A Study of Nivolumab +/- Nab-paclitaxel in Non-small Cell Lung Cancer — TERMINATED · PHASE2
• Study of Lorlatinib in ROS1 Rearranged NSCLC — OTHER · PHASE2
• TQ-B3525 Tablets Combined With Osimertinib Mesylate Tablets in the Treatment of Advanced Non-Small Cell Lung Cancer — OTHER · PHASE1
• Phase I/II Study of Lenalidomide Plus Pembrolizumab in Patients With Solid Tumors With Expansion in Non-small Cell Lung Cancer — TERMINATED · PHASE1
• Metabolic and Microbial Profiling of Lung Cancer — TERMINATED · NA
• SBRT (Stereotactic Body Radiation Therapy) vs. Surgery in High Risk Patients With Early Stage Lung Cancer — COMPLETED · NA
• Compare Apatinib Plus Chemotherapy Drug Versus Chemotherapy Drug as Second-line Treatment in NSCLC — TERMINATED · PHASE2
• Fostering Efficacy of Anti - PD-1 - Treatment: Nivolumab Plus Radiotherapy in Advanced NSCLC — COMPLETED · PHASE2
• Study of Nivolumab for Advanced Cancers in India — COMPLETED · PHASE4
• Assessing an Oral Janus Kinase Inhibitor, AZD4205, in Combination With Osimertinib in Patients Who Have Advanced Non-small Cell Lung Cancer — COMPLETED · PHASE1
• Pazopanib in Molecularly Selected Patients With Advanced NSCLC — TERMINATED · PHASE2
• CT-based Radiomic Signature Can Identify Adenocarcinoma Lung Tumor Histology — OTHER
• Clinical Study of Anlotinib in Maintenance Treatment of Advanced NSCLC — OTHER · NA
• Genomic Landscape of EGFR Mutant NSCLC Prior to Erlotinib and at the Time of Disease Progression — TERMINATED
• The Tracking Molecular Evolution for NSCLC (T-MENC) Study — OTHER
• MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors — TERMINATED · PHASE2
• cSMART Liquid Biopsy and Dynamic Monitor of NSCLC Patients in Inner-Mongolia China — OTHER
• A Mobile Supportive Care App for Patients With Metastatic Lung Cancer — OTHER · NA
• Pacritinib in Patients With Endothelial Growth Factor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC) After EGFR Tyrosine Kinase Inhibitor (TKI) — TERMINATED · PHASE1
• IMRT and Timing in Combination With EGFRTKI for Stage IV Non-small-cell Lung Cancer — OTHER · NA
• Comparison of qPCR to IHC and FISH for Detection of ALK Fusion Mutations in FFPE Tissue From NSCLC Patients — COMPLETED · NA

Refine this search